CAS: 948570-30-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Rontalizumab REF: TM-T81259CAS: 948570-30-7 | >95% | 416.00 €~2,848.00 € | Tue 28 Jan 25 |
 | Rontalizumab REF: 3D-CLA1244CAS: 948570-30-7 | - - - | To inquire | Mon 03 Feb 25 |
Rontalizumab
CAS:948570-30-7
Rontalizumab, a humanized IgG1 monoclonal antibody, targets IFN-α and is utilized in research on systemic …
Purity:
>95%
Color and Shape:
Liquid
Ref: TM-T81259
| 1mg | 416.00 € | ||
| 5mg | 776.00 € | ||
| 10mg | 1,060.00 € | ||
| 25mg | 1,604.00 € | ||
| 50mg | 2,158.00 € | ||
| 100mg | 2,848.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Rontalizumab
CAS:948570-30-7
Anti-IFN-α Humanized monoclonal antibody; potential treatment of systemic lupus erythematosus
Ref: 3D-CLA1244
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 3 Feb 2025
